BALTIMORE — The University of Maryland School of Pharmacy is piloting a program that will allow state employees to receive medication therapy management services, the university announced.
The pilot, offered through the Maryland P3 Program — whose name stands for patients, pharmacists and partnerships — involves the university, the Maryland Department of Health and Mental Hygiene's Office of Chronic Disease Prevention and the Maryland Pharmacists Association. Certain state employees at the State Center office complex in Baltimore will have the opportunity to receive MTM services through the program during the next 14 months. The Maryland P3 Program started operating in summer 2006, and the pilot will be available to 5,000 workers.
"We look forward to demonstrating the program's positive results to determine the potential value-based benefit to the state," Maryland P3 Program director and University of Maryland School of Pharmacy chairwoman Magaly Rodriguez de Bittner said.
According to the school, MTM services have a history of improving outcomes and reducing direct healthcare costs by between $495 and $3,281 per participant each year, due largely to reductions in hospital and emergency room visits.
The pharmacy school will develop, implement and evaluate the effectiveness of the comprehensive MTM services, while pharmacists work with the state workers' primary healthcare providers to assist them with proper use of medications and help with diagnostic testing, counseling and disease management. A more comprehensive program will be available to those who have or who are at risk of developing cardiovascular disease, such as those with hyperlipidemia, hypertension, obesity, diabetes, metabolic syndrome or tobacco dependency.
Are you a pharmacy technician working in the retail industry? Find our group on Facebook for more stories like this and join the conversation.